Unexpected Noncovalent Off-Target Activity of Clinical BTK Inhibitors Leads to Discovery of a Dual NUDT5/14 Antagonist.
Balıkçı E, Marques AMC, Bauer LG, Seupel R, Bennett J, Raux B, Buchan K, Simelis K, Singh U, Rogers C, Ward J, Cheng C, Szommer T, Schützenhofer K, Elkins JM, Sloman DL, Ahel I, Fedorov O, Brennan PE, Huber KVM.
Balıkçı E, et al. Among authors: rogers c.
J Med Chem. 2024 Apr 18. doi: 10.1021/acs.jmedchem.4c00072. Online ahead of print.
J Med Chem. 2024.
PMID: 38635563